ישראל - עברית - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - posaconazole - תרחיף - posaconazole 40 mg/ml - posaconazole - posaconazole - noxafil is indicated for use in the treatment of the following fungal infections in adults : - invasive aspergillosis in patients with disease that is refractory to amphotericin b or itraconazole or in patients who are intolerant of these medicinal products - fusariosis in patients with disease that is refractory to amphotericin b or in patients who are intolerant of amphotericin b - chromoblastomycosis and mycetoma in patients with disease that is refractory to itraconazole or in patients who are intolerant of itraconazole - coccidioidomycosis in patients with disease that is refractory to amphotericin b itraconazole or fluconazole or in patients who are intolerant of these medicinal products - oropharyngeal candidiasis : as first - line therapy in patients who have severe disease or are immunocompromised in whom response to topical therapy is expected to be poor. refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective anti

ישראל - עברית - Ministry of Health

merck sharp & dohme israel ltd - posaconazole - תרחיף - posaconazole 40 mg/ml - posaconazole - posaconazole - noxafil is indicated for use in the treatment of the following fungal infections in adults : - invasive aspergillosis in patients with disease that is refractory to amphotericin b or itraconazole or in patients who are intolerant of these medicinal products - fusariosis in patients with disease that is refractory to amphotericin b or in patients who are intolerant of amphotericin b - chromoblastomycosis and mycetoma in patients with disease that is refractory to itraconazole or in patients who are intolerant of itraconazole - coccidioidomycosis in patients with disease that is refractory to amphotericin b itraconazole or fluconazole or in patients who are intolerant of these medicinal products - oropharyngeal candidiasis : as first - line therapy in patients who have severe disease or are immunocompromised in whom response to topical therapy is expected to be poor. refractoriness is defined as progression of infection or failure to improve after a minimum of 7 days of prior therapeutic doses of effective anti

ישראל - עברית - Ministry of Health

j-c health care ltd - miconazole nitrate - קרם - miconazole nitrate 20 mg/g - miconazole - miconazole - broad spectrum antimycotic

ישראל - עברית - Ministry of Health

j-c health care ltd - miconazole - ג'ל - miconazole 20 mg/g - miconazole - miconazole - oral mycosis (thrush) and fungal infections of the upper gastrointestinal tract. daktarin oral gel can be used for the prevention of oral thrush in patient receiving long-term treatment with antibiotics, steroids, cytotoxic and radiation therapy.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - miconazole nitrate - קרם - miconazole nitrate 2 % - miconazole - miconazole - skin and nail infections due to dermatophytes or candida.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - miconazole nitrate - קרם - miconazole nitrate 2 % - miconazole - miconazole - skin and nail infections due to dermatophytes or candida.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - fluconazole - קפסולות - fluconazole 50 mg - fluconazole - fluconazole - cryptococcosis. systemic candidiasis. mucosal candidiasis. vaginal candidiasis.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - fluconazole - קפסולות - fluconazole 100 mg - fluconazole - fluconazole - cryptococcosis. systemic candidiasis. mucosal candidiasis. vaginal candidiasis.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - fluconazole - קפסולות - fluconazole 200 mg - fluconazole - fluconazole - cryptococcosis. systemic candidiasis. mucosal candidiasis. vaginal candidiasis.

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - fluconazole - קפסולות - fluconazole 150 mg - fluconazole - fluconazole - cryptococcosis. - systemic candidiasis. - mucosal candidiasis. - vaginal candidiasis. - dermatomycosis.